ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 196 filers reported holding ARRAY BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $290,000 | -25.3% | 11,900 | -48.5% | 0.06% | -35.6% |
| Q2 2018 | $388,000 | +80.5% | 23,100 | +75.0% | 0.09% | +58.2% |
| Q1 2018 | $215,000 | +24.3% | 13,200 | -6.4% | 0.06% | +34.1% |
| Q3 2017 | $173,000 | -39.5% | 14,100 | -58.8% | 0.04% | -61.0% |
| Q2 2017 | $286,000 | -35.3% | 34,200 | -30.8% | 0.10% | -50.0% |
| Q1 2017 | $442,000 | – | 49,400 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |